93 related articles for article (PubMed ID: 15019295)
1. Impact of tumor-derived CCL2 on T cell effector function.
Vitiello PF; Shainheit MG; Allison EM; Adler EP; Kurt RA
Immunol Lett; 2004 Feb; 91(2-3):239-45. PubMed ID: 15019295
[TBL] [Abstract][Full Text] [Related]
2. The expression of CCL2 by T lymphocytes of mammary tumor bearers: role of tumor-derived factors.
Owen JL; Lopez DM; Grosso JF; Guthrie KM; Herbert LM; Torroella-Kouri M; Iragavarapu-Charyulu V
Cell Immunol; 2005 Jun; 235(2):122-35. PubMed ID: 16243300
[TBL] [Abstract][Full Text] [Related]
3. Potential involvement of monocyte chemoattractant protein (MCP)-1/CCL2 in IL-4-mediated tumor immunity through inducing dendritic cell migration into the draining lymph nodes.
Wang H; Nemoto-Sasaki Y; Kondo T; Akiyama M; Mukaida N
Int Immunopharmacol; 2003 May; 3(5):627-42. PubMed ID: 12757733
[TBL] [Abstract][Full Text] [Related]
4. GM-CSF up-regulates the expression of CCL2 by T lymphocytes in mammary tumor-bearing mice.
Owen JL; Torroella-Kouri M; Handel-Fernandez ME; Iragavarapu-Charyulu V
Int J Mol Med; 2007 Jul; 20(1):129-36. PubMed ID: 17549399
[TBL] [Abstract][Full Text] [Related]
5. Microenvironment of the murine mammary carcinoma 4T1: endogenous IFN-gamma affects tumor phenotype, growth, and metastasis.
duPre' SA; Redelman D; Hunter KW
Exp Mol Pathol; 2008 Dec; 85(3):174-88. PubMed ID: 18929358
[TBL] [Abstract][Full Text] [Related]
6. Potent in vivo anti-tumor activity of isolated CD62L(low) lymph node cells sensitized in vivo with tumor lysate-pulsed DC-based vaccines.
Liu Z; Fan H; Wu Y; Chen B
Cytotherapy; 2005; 7(4):353-62. PubMed ID: 16162457
[TBL] [Abstract][Full Text] [Related]
7. In situ expression of IFN-gamma-inducible T cell alpha chemoattractant in breast cancer mounts an enhanced specific anti-tumor immunity which leads to tumor regression.
Chu Y; Yang X; Xu W; Wang Y; Guo Q; Xiong S
Cancer Immunol Immunother; 2007 Oct; 56(10):1539-49. PubMed ID: 17659370
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy and anti-tumor immunity.
Gollnick SO; Owczarczak B; Maier P
Lasers Surg Med; 2006 Jun; 38(5):509-15. PubMed ID: 16788921
[TBL] [Abstract][Full Text] [Related]
9. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity.
Yang X; Chu Y; Wang Y; Zhang R; Xiong S
J Leukoc Biol; 2006 Dec; 80(6):1434-44. PubMed ID: 16980511
[TBL] [Abstract][Full Text] [Related]
10. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
11. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
[TBL] [Abstract][Full Text] [Related]
12. Involvement of CC chemokines in gammadelta T lymphocyte trafficking during allergic inflammation: the role of CCL2/CCR2 pathway.
Penido C; Costa MF; Souza MC; Costa KA; Candéa AL; Benjamim CF; Henriques Md
Int Immunol; 2008 Jan; 20(1):129-39. PubMed ID: 18056919
[TBL] [Abstract][Full Text] [Related]
13. CCL2 as a trigger of manifestations of compensatory anti-inflammatory response syndrome in mice with severe systemic inflammatory response syndrome.
Takahashi H; Tsuda Y; Kobayashi M; Herndon DN; Suzuki F
J Leukoc Biol; 2006 Apr; 79(4):789-96. PubMed ID: 16434696
[TBL] [Abstract][Full Text] [Related]
14. CC chemokine receptor 7 expression by effector/memory CD4+ T cells depends on antigen specificity and tissue localization during influenza A virus infection.
Debes GF; Bonhagen K; Wolff T; Kretschmer U; Krautwald S; Kamradt T; Hamann A
J Virol; 2004 Jul; 78(14):7528-35. PubMed ID: 15220427
[TBL] [Abstract][Full Text] [Related]
15. Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment.
Kuroda T; Kitadai Y; Tanaka S; Yang X; Mukaida N; Yoshihara M; Chayama K
Clin Cancer Res; 2005 Nov; 11(21):7629-36. PubMed ID: 16278381
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived CCL5 does not contribute to breast cancer progression.
Jayasinghe MM; Golden JM; Nair P; O'Donnell CM; Werner MT; Kurt RA
Breast Cancer Res Treat; 2008 Oct; 111(3):511-21. PubMed ID: 17978871
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysacchride-treated mammary carcinomas secrete proinflammatory chemokines and exhibit reduced growth rates in vivo, but not in vitro.
Nair P; O'Donnell CM; Janasek K; Sajduk MK; Smith EA; Golden JM; Vasta CA; Huggins AB; Kurt RA
Immunol Invest; 2009; 38(8):730-48. PubMed ID: 19860585
[TBL] [Abstract][Full Text] [Related]
18. Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice.
Owen JL; Torroella-Kouri M; Iragavarapu-Charyulu V
Int J Mol Med; 2008 Jan; 21(1):125-34. PubMed ID: 18097625
[TBL] [Abstract][Full Text] [Related]
19. Induction of T-cell antitumor immunity and protection against tumor growth by secretion of soluble human CD70 molecules.
Cormary C; Gonzalez R; Faye JC; Favre G; Tilkin-Mariamé AF
Cancer Gene Ther; 2004 Jul; 11(7):497-507. PubMed ID: 15153937
[TBL] [Abstract][Full Text] [Related]
20. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
